Cholecalciferol Supplementation in Relapsing Multiple Sclerosis Patients Treated with Subcutaneous Interferon Beta-1A: a Randomized Controlled Trial. (S44.004)

William Camu,Charles Pierrot‐Deseilligny,Patrick Hautecœur,Anne Besserve,Anne-Sophie Jean Deleglise,Philippe Lehert,Jean‐Claude Souberbielle

Neurology（2017）

引用 23|浏览3

暂无评分

摘要

To evaluate the benefit of add-on therapy withVitamin D3 100 kIU twice monthly over 2 years in relapsing multiplesclerosis (RMS) patients treated with subcutaneous interferon beta-1a 44 μg 3 times weekly.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要